Navigation Links
Recognizing blood poisoning quickly
Date:12/9/2011

Is the patient suffering from blood poisoning? To answer this question, the doctor draws a blood sample and sends it to a central laboratory for testing. This takes up valuable time, which could cost the patient his life. In future, physicians will be able to analyze blood there and then and have the results within twenty minutes. This is made possible by a biochip, developed by scientists at the Fraunhofer Institute for Physical Measurement Techniques IPM in Freiburg. "To analyze the biochip we have also designed a fully automatic device to carry out all the examination steps," explains Dr. Albrecht Brandenburg, group manager at the IPM. "All the doctor has to do is place the sample in the apparatus and wait for the results."

Meanwhile, within the device there's plenty going on: it starts by preparing the blood sample. Red blood cells are separated from the blood and the plasma that remains is guided onto the biochip. When patients are suffering from sepsis, their immune system reacts by producing certain proteins. The biochip uses these in its diagnosis: there are antibodies positioned on the chip which fit these proteins like a key fits a lock. If the proteins are present in the blood, the antibodies fish them out of the fluid and bind them to the chip. But how does the apparatus know if proteins have been caught? "The chip is rinsed with a solution containing the appropriate antibodies, which have in turn been marked with a fluorescent dye," explains IPM scientist Dr. Manuel Kemmler. "These bind to the proteins meaning antibodies, protein and marked antibodies are all firmly linked to each other and to the chip's surface. When the chip is illuminated, the dye lights up." The apparatus sees lots of little illuminated dots that show the protein was in the blood. If the patient is healthy, however, the chip remains dark.

The researchers can even test for different proteins at the same time in one cycle. This is done by placing various different catcher molecules on the chip, to which specific molecules in the blood attach themselves. A cunning selection of proven protein markers allows the scientists to obtain additional important information about the severity and cause of the illness.

Together with colleagues from a university hospital, the researchers have already successfully tested prototypes of the device and biochip. Each biochip can only be used once so they have to be affordable. "We predict that in the long run, with production on a large enough scale, each chip will cost no more than one euro," says Brandenburg. There are various possible applications: other conditions such as heart attacks or cancers can also be investigated this way. What's more, the chip facilitates doping and urine testing as well as the quality assessment of foodstuffs.


'/>"/>
Contact: Dr. Albrecht Brandenburg
albrecht.brandenburg@ipm.fraunhofer.de
49-761-885-7306
Fraunhofer-Gesellschaft
Source:Eurekalert  

Related biology news :

1. MIT: Why we have difficulty recognizing faces in photo negatives
2. Psychologists find skill in recognizing faces peaks after age 30
3. Recognizing gibbons from their regional accents
4. Scientist plans to test for blood pressure genes affected by age
5. Discovery of natural compounds that could slow blood vessel growth
6. New blood test for Down syndrome
7. On the trail of a targeted therapy for blood cancers
8. Lower your blood pressure, hydrate your skin and reduce dental plaque -- with chocolate?
9. Building the blood-brain barrier
10. Apelin hormone injections powerfully lower blood sugar
11. Battling bacteria in the blood: Researchers tackle deadly infections
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Recognizing blood poisoning quickly
(Date:2/2/2016)... , Feb. 2, 2016  Based on ... Frost & Sullivan recognizes US-based Intelligent Retinal Imaging ... & Sullivan Award for New Product Innovation. IRIS, ... North America , is poised ... rapidly growing diabetic retinopathy market. The IRIS technology ...
(Date:2/1/2016)... 2016  Today, the first day of American Heart ... develop a first of its kind workplace health solution ... In the first application of Watson ... ), and Welltok will create a new offering that ... analytics, delivered on Welltok,s health optimization platform. The effort ...
(Date:1/28/2016)... SAN JOSE, Calif., Jan. 28, 2016 Synaptics (NASDAQ: ... financial results for its second quarter ended December 31, 2015. ... the second quarter of fiscal 2016 increased 2 percent compared to ... the second quarter of fiscal 2016 was $35.0 million, or $0.93 ... Non-GAAP net income for the first quarter of fiscal 2016 ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... 2016  Spherix Incorporated (Nasdaq: SPEX ) -- an intellectual ... of intellectual property, today provided an update on the ... District of Texas and announcing ... Inter Partes Re-examination ("IPR") proceedings that VTech and ... was initiated on only certain claims of two of ...
(Date:2/3/2016)... DIEGO , Feb. 3, 2016   ... company with the first pluripotent stem cell-derived islet ... diabetes in clinical-stage development, today announced that ViaCyte ... Pharmaceutical Companies of Johnson & Johnson, have agreed ... group into ViaCyte.  The agreement provides ViaCyte with ...
(Date:2/3/2016)... NEW BRUNSWICK, N.J. , Feb. 3, 2016 ... 30 grants totaling more than $1 million for ... who are working on health-related research that demonstrates ... , this round of funding for the New ... available for faculty members at these educational institutions— ...
(Date:2/3/2016)... Feb. 3, 2016  Silk Therapeutics, Inc., today announced the ... Therapeutics has now raised a total of $10.25 million in ... company. The Series A2 round was led by existing investor ... with participation from new investors Lear Corporation and Highland Consumer ... P. Disney ; Richard Sackler , MD, with Summer ...
Breaking Biology Technology: